A detailed history of Entry Point Capital, LLC transactions in Xencor Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 6,749 shares of XNCR stock, worth $141,863. This represents 0.19% of its overall portfolio holdings.

Number of Shares
6,749
Previous 14,306 52.82%
Holding current value
$141,863
Previous $317 Million 59.65%
% of portfolio
0.19%
Previous 0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$18.21 - $24.5 $137,612 - $185,146
-7,557 Reduced 52.82%
6,749 $128 Million
Q1 2024

May 14, 2024

SELL
$18.65 - $26.52 $20,757 - $29,516
-1,113 Reduced 7.22%
14,306 $317 Million
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $254,876 - $330,274
15,419 New
15,419 $327 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.25B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.